Bioverativ
Enjaymo
Manufacturer:
Bioverativ
Name:
Enjaymo
Category:
J Code
HCPCS:
J1302
NDC(s):
80203-0347-01,
Primary Type:
Monoclonal Antibody
Route of Administration:
Intravenous
About:
Enjaymo is a Monoclonal Antibody drug manufactured by Bioverativ and administered via the Intravenous route of administration. The J Code: J1302 is aligned to the drug Enjaymo.